Overview

Cost and efficiency will continue to be a dominant topic in most light manufacturing environments. Effective use of modern manufacturing methodologies to streamline costs and reduce waste are the norm. Digitization of the manufacturing floor and increasing supply chain transparency will continue to evolve with technology development. Sustainability pressure will continue with ever increasing awareness of the environmental cost of doing business.

While winning companies will demonstrate strength in all of these areas, they must also excel at taking pressure off their operating margins by optimizing their commercial opportunities and making the necessary structural decisions as they evolve.

Our Capabilities

  • Vibrant product development & life cycle management

  • Successful M&A - identification, negotiation, integration, leveraging

  • Price optimization

Our Experience

Over 30 years of light manufacturing and assembly experience in chemical formulation and processing, injection molding, extrusion & thermo-forming, electro-mechanical capital equipment design & assembly, precision machining and high volume packaging in regulated environments. Experience includes greenfield factory development, site transfer and rationalization and process optimization.

For additional insight, please explore CASE STUDIES below.


CASE STUDIES

Multiple Acquisition Integrations3 separate sub $100M founder owned medical device companiesConsumable materials & devicesUnited States, Europe, Asia

Multiple Acquisition Integrations

3 separate sub $100M founder owned medical device companies

Consumable materials & devices

United States, Europe, Asia

Price OptimizationMultiple $100M+ subsidiaries of $3B public medical device companyConsumable materials & equipmentUnited States

Price Optimization

Multiple $100M+ subsidiaries of $3B public medical device company

Consumable materials & equipment

United States

Product Portfolio TransformationSub $100M subsidiary of $3B public medical device companyConsumable injection molded devicesUnited States

Product Portfolio Transformation

Sub $100M subsidiary of $3B public medical device company

Consumable injection molded devices

United States